• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities
    Health Care
    Get the next $AHCO alert in real time by email

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024.

    Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served as Vice President, General Manager of the Health Systems Operating Division at Labcorp (NYSE:LH). Previously, Mr. Nair served as Senior Vice President at Thrive Skilled Pediatric Care, and as Vice President of Operations at AdaptHealth (NASDAQ:AHCO). Mr. Nair graduated from the prestigious Bronx High School of Science, holds a B.A. in Business Administration from Sacramento International University, and earned his MBA in Public Accounting from the Tobin College of Business at Saint John's University.

    "We are thrilled to welcome Dino to Advantage," said Timothy Bovard, Chairperson of the Board of Advantage. "Our Board conducted an extensive search and Dino stood out as the ideal fit for us. With his extensive experience in healthcare, particularly sleep and pulmonary therapy, we are confident Dino has the skills and exemplary leadership to lead Advantage as it looks to grow and expand its ability to improve outcomes for more patients through personalized care."

    "I am excited to join the Advantage family, and lead the Company in our continued growth, building on the positive energy that has been established," Mr. Nair said. "I look forward to collaborating closely with our team to execute initiatives to drive improved patient outcomes through greater access, while delivering value to our customers and stakeholders."

    "On behalf of the Board of Directors, we would like to thank Ryan for his leadership," said Mr. Bovard. "He led the Company through some challenging times and is delivering a business poised for growth to Dino."

    About Advantage Healthcare Holdings

    Advantage is a regional leader in managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers (Sleep Labs). The Company provides a wide array of services, including Physical Therapy, Occupational Therapy, Pulmonary Rehabilitation, In-Lab Sleep Testing, Home Sleep Testing, and Remote Patient Monitoring. Advantage also runs an Accredited Sleep Technologist Education Program (A-STEP).

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240925779746/en/

    Get the next $AHCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHCO
    $LH

    CompanyDatePrice TargetRatingAnalyst
    Labcorp Holdings Inc.
    $LH
    7/10/2025$260.00Buy → Hold
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    4/2/2025$276.00Buy
    Redburn Atlantic
    Labcorp Holdings Inc.
    $LH
    3/4/2025$250.00 → $300.00Neutral → Buy
    Citigroup
    Labcorp Holdings Inc.
    $LH
    1/7/2025$260.00 → $265.00In-line → Outperform
    Evercore ISI
    Labcorp Holdings Inc.
    $LH
    12/10/2024$265.00 → $275.00Buy
    Jefferies
    Labcorp Holdings Inc.
    $LH
    10/30/2024Hold → Buy
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    10/1/2024$235.00Neutral
    Piper Sandler
    Labcorp Holdings Inc.
    $LH
    3/25/2024$250.00Hold → Buy
    Argus
    More analyst ratings

    $AHCO
    $LH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

    Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer's disease through early detection of the amyloid plaques associated with the disease in appropriate patients. Developed by Fujirebio Diagnostics, Inc., the test is now available nationwide through Labcorp.

    8/18/25 7:00:00 AM ET
    $LH
    Medical Specialities
    Health Care

    AdaptHealth Corp. Announces Second Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%. Net income attributable to AdaptHealth Corp. was $14.7 million compared to net income of $19.4 million. Adjusted EBITDA was $155.5 million compared to $165.3 million, a decrease of 5.9%. Cas

    8/5/25 7:01:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Partners With a Major National Healthcare System to Become the Exclusive Provider of Home Medical Equipment

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has entered into a definitive agreement with a major national healthcare system. Under the agreement, AdaptHealth will serve as the exclusive provider of home medical equipment and supplies across the healthcare system's broad network of hospitals and medical offices. The 5-year agreement, which is subject to certain termination provisions, is structured primarily as a capitation payment model and covers all of the system's more than 10 million members.

    8/5/25 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    $LH
    SEC Filings

    View All

    SEC Form 144 filed by Labcorp Holdings Inc.

    144 - LABCORP HOLDINGS INC. (0000920148) (Subject)

    8/11/25 9:50:12 AM ET
    $LH
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by AdaptHealth Corp.

    SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)

    8/6/25 11:51:35 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by AdaptHealth Corp.

    10-Q - AdaptHealth Corp. (0001725255) (Filer)

    8/5/25 5:09:33 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    $LH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Labcorp Holdings Inc. downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Labcorp Holdings Inc. from Buy to Hold and set a new price target of $260.00

    7/10/25 9:03:30 AM ET
    $LH
    Medical Specialities
    Health Care

    Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

    Redburn Atlantic initiated coverage of Labcorp Holdings Inc. with a rating of Buy and set a new price target of $276.00

    4/2/25 8:50:29 AM ET
    $LH
    Medical Specialities
    Health Care

    Labcorp Holdings Inc. upgraded by Citigroup with a new price target

    Citigroup upgraded Labcorp Holdings Inc. from Neutral to Buy and set a new price target of $300.00 from $250.00 previously

    3/4/25 7:36:42 AM ET
    $LH
    Medical Specialities
    Health Care

    $AHCO
    $LH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Legal Officer Van Der Vaart Sandra D exercised 3,903 shares at a strike of $131.43 and sold $1,059,371 worth of shares (3,903 units at $271.42) (SEC Form 4)

    4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    8/15/25 10:55:59 AM ET
    $LH
    Medical Specialities
    Health Care

    President & CEO Schechter Adam H sold $1,505,440 worth of shares (5,643 units at $266.78), decreasing direct ownership by 6% to 93,319 units (SEC Form 4)

    4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    8/13/25 12:29:58 PM ET
    $LH
    Medical Specialities
    Health Care

    Director Gilliland Dwight Gary sold $529,900 worth of shares (2,000 units at $264.95), decreasing direct ownership by 23% to 6,656 units (SEC Form 4)

    4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    8/1/25 8:44:32 AM ET
    $LH
    Medical Specialities
    Health Care

    $AHCO
    $LH
    Financials

    Live finance-specific insights

    View All

    AdaptHealth Corp. Announces Second Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%. Net income attributable to AdaptHealth Corp. was $14.7 million compared to net income of $19.4 million. Adjusted EBITDA was $155.5 million compared to $165.3 million, a decrease of 5.9%. Cas

    8/5/25 7:01:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Labcorp Announces 2025 Second Quarter Results

    Raises Full-Year Guidance Financial results from Operations for second quarter 2025 versus second quarter 2024:Revenue: $3.53 billion versus $3.22 billionDiluted EPS: $2.84 versus $2.43Adjusted EPS: $4.35 versus $3.94Raised Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance:Revenue guidance narrowed to 7.5% to 8.6%; midpoint raised by 70 basis pointsAdjusted EPS range narrowed to $16.05 to $16.50; midpoint raised by $0.23Free Cash Flow range of $1.13 billion to $1.28 billion; midpoint raised by $25 millionBroadened our partnerships with hospitals, health systems and regional/local labs and enhanced access to comprehensive testing and laboratory servicesIntroduced several new tests

    7/24/25 6:50:00 AM ET
    $LH
    Medical Specialities
    Health Care

    AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2025 financial results before the opening of the financial markets on Tuesday, August 5, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q25 Webcast registration: Click Here Followin

    7/15/25 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    $LH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/14/24 9:03:31 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AdaptHealth Corp.

    SC 13G - AdaptHealth Corp. (0001725255) (Subject)

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/12/24 1:30:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    $LH
    Leadership Updates

    Live Leadership Updates

    View All

    Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

    ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. "We are excited to welcome Lance to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as

    7/8/25 9:00:00 AM ET
    $LH
    $PRVA
    Medical Specialities
    Health Care
    Medical/Nursing Services

    SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

    SOLVD Health (SOLVD), a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has appointed diagnostics pioneer Mike Aicher and strategic advisor Vince Cebula to its Board of Directors. Their combined leadership in molecular diagnostics, healthcare technology, and growth-stage investment will support the company's continued expansion as it scales access to personalized health insights and accelerates development of its precision diagnostics platform. Aicher's expertise in building and scaling diagnostic platforms will be instrumental as SOLVD Health expands its personalized health solutions. He brings more than three decades of executiv

    5/12/25 9:00:00 AM ET
    $LH
    Medical Specialities
    Health Care

    AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

    12/3/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care